Latest Hepcidin Stories
DALLAS, March 26, 2015 /PRNewswire/ -- RnRMarketResearch.com adds "Thalassemia - Pipeline Review, H1 2015" therapeutic market research report of 100 pages with latest updates,
- Announces new messenger RNA therapeutics pipeline using LUNAR(TM) delivery technology and UNA-messenger RNA (UmRNA) SAN DIEGO, Jan.
Negative iron balance predicts survival in patients with acute heart failure.
A UCLA research team has found no evidence of an association between iron levels in the body and the risk of atherosclerosis, the hardening and narrowing of the arteries that leads to cardiovascular disease, the No. 1 killer in the U.S.
Researchers at Emory University School of Medicine have identified hepcidin, a hormone that regulates iron levels in the body, as a potential target for treating atherosclerosis.
Multiple organs, including the liver and the heart, become damaged if an individual has an excessive amount of iron in their body.
Iron overload is a common condition affecting millions of people worldwide.
- A woman chauffeur.
- A woman who operates an automobile.